| Financial Year |
March 31 2023 |
| Monetary Funds |
2,076,708,729.10 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
28,440,692.04 |
| Accounts Receivable |
474,018,338.75 |
| Advances to Suppliers |
22,083,329.74 |
| Other Receivables |
10,239,619.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,454,951,100.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,494,704.23 |
| Total Current Assets |
4,137,890,568.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
639,092,329.49 |
| Under-construction Projects |
411,562,737.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
209,289,413.74 |
| R&D expenses |
-- |
| Goodwill |
201,572,522.49 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
56,606,733.14 |
| Other Non-Current Assets |
64,708,857.14 |
| Sub-Total of Non-Current Assets |
1,683,050,397.25 |
| Total Assets |
5,820,940,965.35 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
76,339,577.53 |
| Notes Payable |
118,008,410.84 |
| Accounts Payable |
371,934,458.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
108,111,622.22 |
| Taxes Payable |
23,572,214.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,161,243.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,120,019.51 |
| Other Current Liabilities |
8,359,910.16 |
| Sub-Total of Current Liabilities |
769,383,476.75 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
41,177,453.63 |
| Other Non-Current Liabilities |
38,685,814.41 |
| Sub-Total of Non-Current Liabilities |
113,382,378.52 |
| Total Liabilities |
882,765,855.27 |
| Paid-In Capital(Or Share Stock) |
507,086,219.00 |
| Capital Surplus |
1,729,257,347.26 |
| Surplus Reserve |
133,371,823.04 |
| LESS:Treasury Stock |
129,874.40 |
| Undistributed Profits |
2,566,695,126.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,938,175,110.08 |
| Owner's Equity（Stockholder's Equity） |
4,938,175,110.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,820,940,965.35 |
